
ASSOCIATIONS BETWEEN VARIATIONS IN TPH1, TPH2
AND SLC6A4 GENES AND POSTPARTUM DEPRESSION:
A STUDY IN THE JORDANIAN POPULATION Khabour OF1, Amarneh BH2, Bani Hani EA3, Lataifeh IM4 *Corresponding Author: Dr. Omar F. Khabour, Associate Professor of Molecular Genetics, Department of Medical
Laboratory, Sciences, Jordan University of Science and Technology, PO Box 3030, Irbid 22110, Jordan; Tel.:
+962-2-720-1000 ext. 23784; Fax: +962-2-720-1087; E-mail: khabour@just.edu.jo page: 41
|
MATERIALS AND METHODS
Subjects. This prospective cross-sectional study
involved 370 randomly selected postpartum women
(240 controls and 130 depressed cases) from five maternity
centers in Irbid, Jordan. Random selection was
carried out based on locations of the clinics in the city
and type of clinic (public vs. private). Women with pre
existing psychiatric disorders were excluded from the
study. Women were recruited 4 to 6 weeks after child
delivery. Informed written consent was obtained from
all subjects in accordance with the requirements of the
Institutional Review Boards of Jordan University of
Science and Technology, Irbid, Jordan.
Edinburgh Postnatal Depression Scale Questionnaire.
An Arabic version of the Edinburgh Postnatal
Depression Scale (EPDS) was used to screen
postpartum
women [21]. An EPDS score >13 was
used as a criterion to indicate the presence of depression
illness(es) [21]. This cut-off value has been
reported to have high sensitivity and specificity.
Several demographic variables were also included
in the questionnaire to assess the possible correlation
between PPD and some environmental factors such
as maternal age, educational level, income satisfaction,
number of children, delivery mode, depression
history and pregnancy problems.
DNA Extraction. Venous blood samples were
collected in EDTA tubes and obtained from all subjects.
DNA was extracted using Promega wizard
genomic DNA purification kit (Promega, Madison,
WI, USA) according to the protocol provided by the
manufacturer. DNA concentrations were measured
using Smart-SpectTM3000 (Bio-Rad Laboratories,
Hemel Hempstead, Hertfordshire, UK). Extracted
DNA was stored at –20°C until used.
Genotyping of the TPH1 (218A>C) Polymorphism.
TPH1 was analyzed using polymerase chain
reaction (PCR) followed by the restriction fragment
length polymorphism (RFLP) method. The TPH1
gene fragment was amplified using primers described
previously [22]. The reaction mixture of 25 mL contained
5 ng of genomic DNA, 1 mM of each primer,
green master mix (Promega), 1 mM of spermidine and
H2O. The reaction mixture was initially denatured at
95°C for 5 min., followed by 30 cycles at 95°C for
30 seconds, 55°C for 30 seconds and 72°C for 30
seconds. The PCR was completed by a final extension
cycle at 72°C for 5 min. Successful amplification of
the fragment was confirmed by detection of a 847 bp
band on a 2.0% agarose gel. The restriction enzyme
digestion was carried out overnight at 37°C in a 20 mL
volume reaction mixture containing 10 mL of the amplified
PCR product and 1 unit of Bfa1. The digested
fragments were then separated using 2.0% agarose
gel electrophoresis and detected by ethidium bromide staining. The PCR product with the A allele remained
uncut (847 bp), whereas the digested PCR product
with the C allele gave fragments of 599 and 248 bp.
Genotyping of the TPH2 (1463G>A) Polymorphism.
Allele-specific PCR using amplification refractory
mutation system (ARMS) method was used
for analyzing the TPH2 G1463A polymorphism as
described by Zhang et al. [12]. Only the G allele PCRspecific
product was detected in the DNA obtained
from participating women, while the A allele product
was not detected. Validity of the ARMS results was
achieved by sequencing of more than 10.0% of the
PCR products using ABI PRISM™ 3.1 automated
sequencer (Life Technologies, Applied Biosystems,
Foster City, CA, USA) as previously described [23].
Genotyping of the SLC6A4 (L/S) Polymorphism.
The SLC6A4 (L/S) polymorphism was analyzed
using PCR. Desired DNA target sequences,
469 bp for the S allele and 513 bp for the L allele,
were amplified as described by Middledorp et al.
[24]. The reaction mixture of 20 mL contained 5 ng
of genomic DNA, 1 mM of each primer, Promega
green master mix, 2.0% DMSO and H2O. The reaction
mixture was initially denatured at 94°C for 3
min., followed by 35 cycles at 94°C for 30 seconds,
59°C for 30 seconds and 72°C for 90 seconds. The
PCR procedure was terminated by a final extension
at 72°C for 6 min. Amplified 469 or 513 bp fragments
were electrophoresed through 2.0% agarose
and visualized by ultraviolet illumination upon ethidium
bromide staining.
Statistical Analyses. Data analysis was carried
out using the statistical package for social studies
(SPSS) version 17 (SPSS Inc., Chicago, IL, USA)
to compute all de-scriptive statistics. The chi-squate
(c2) test was used to identify the correlation between
the studied demographic variables and PPD. If n <5,
exact Fisher statistic test was used. In addition, the
same tests were used to evaluate the genotype distribution
and allele frequencies of the three studied
polymorphisms. The test power was calculated for
allele and genotype frequencies using Power and
Sample Size Calculation Program (PS version 3.0.1;
Vanderbilt University Medical Center, Nashville, TN,
USA). For all analyses, the power was more than
75.0%. A p value <0.05 was considered significant.
The Hardy-Weinberg equilibrium was assessed using
the c2 test.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|